Verma V, Beevi S, Nair R, Kumar A, Kiran R, Alexander L
Cell Commun Signal. 2024; 22(1):100.
PMID: 38326829
PMC: 10851529.
DOI: 10.1186/s12964-023-01452-2.
Chen J, Xie T, Yang J, Lin X, Huang L, Su S
J Cancer Res Clin Oncol. 2023; 149(11):8699-8709.
PMID: 37127827
DOI: 10.1007/s00432-023-04819-7.
Kurniali P, Storandt M, Jin Z
J Pers Med. 2023; 13(4).
PMID: 37109080
PMC: 10145886.
DOI: 10.3390/jpm13040694.
Zhang Q, Kong D, Yang Z, Li G, Cheng S, Feng L
Clin Exp Med. 2023; 23(6):1933-1944.
PMID: 36735207
DOI: 10.1007/s10238-023-01009-0.
Marcu L, Moghaddasi L, Bezak E
Int J Mol Sci. 2023; 24(2).
PMID: 36675033
PMC: 9864237.
DOI: 10.3390/ijms24021524.
Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer.
Yi-Wen W, Long-Long L, Ming L, Hao L, Kong-Wang H
Arch Med Sci. 2022; 18(5):1297-1307.
PMID: 36160346
PMC: 9479591.
DOI: 10.5114/aoms.2020.97707.
Sensitizing drug-resistant cancer cells from blood using microfluidic electroporator.
Sung H, Choi S, Chu C, Ouyang M, Kalyan S, Scott N
PLoS One. 2022; 17(3):e0264907.
PMID: 35259174
PMC: 8903260.
DOI: 10.1371/journal.pone.0264907.
Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients.
Carneiro A, Piairo P, Teixeira A, Ferreira D, Cotton S, Rodrigues C
Cells. 2022; 11(3).
PMID: 35159186
PMC: 8834092.
DOI: 10.3390/cells11030376.
Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis.
Wan L, Liu Q, Liang D, Guo Y, Liu G, Ren J
Front Oncol. 2021; 11:630672.
PMID: 34136379
PMC: 8202280.
DOI: 10.3389/fonc.2021.630672.
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide.
Del Re M, Conteduca V, Crucitta S, Gurioli G, Casadei C, Restante G
Prostate Cancer Prostatic Dis. 2021; 24(2):524-531.
PMID: 33500577
PMC: 8134038.
DOI: 10.1038/s41391-020-00309-w.
In Vivo Lymphatic Circulating Tumor Cells and Progression of Metastatic Disease.
Han M, Watts J, Jamshidi-Parsian A, Nadeem U, Sarimollaoglu M, Siegel E
Cancers (Basel). 2020; 12(10).
PMID: 33028044
PMC: 7650582.
DOI: 10.3390/cancers12102866.
Development and Clinical Prospects of Techniques to Separate Circulating Tumor Cells from Peripheral Blood.
Tian C, Xu X, Wang Y, Li D, Lu H, Yang Z
Cancer Manag Res. 2020; 12:7263-7275.
PMID: 32884342
PMC: 7434565.
DOI: 10.2147/CMAR.S248380.
Detection of circulating tumor cells in patients with breast cancer using the conditionally reprogrammed cell culture method and reverse transcription-PCR of and .
Jeong Y, Park S, Jeon C
Oncol Lett. 2020; 20(4):78.
PMID: 32863911
PMC: 7436930.
DOI: 10.3892/ol.2020.11939.
Longitudinal Monitoring of and Mutations by Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports.
Li N, Guha U, Kim C, Ye L, Cheng J, Li F
Front Oncol. 2020; 10:1240.
PMID: 32793495
PMC: 7393232.
DOI: 10.3389/fonc.2020.01240.
Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity.
Koch C, Kuske A, Joosse S, Yigit G, Sflomos G, Thaler S
EMBO Mol Med. 2020; 12(9):e11908.
PMID: 32667137
PMC: 7507517.
DOI: 10.15252/emmm.201911908.
Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell Carcinoma.
Ko J, Ng H, Lam K, Chiu K, Kwong D, Lo A
Cancers (Basel). 2020; 12(6).
PMID: 32466419
PMC: 7352685.
DOI: 10.3390/cancers12061352.
Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer.
Duan G, Zhang X, Wang H, Wang Z, Zhang H, Yu L
Onco Targets Ther. 2020; 13:1931-1939.
PMID: 32184628
PMC: 7061431.
DOI: 10.2147/OTT.S241956.
Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis.
Gao Y, Xi H, Wei B, Cui J, Zhang K, Li H
Front Oncol. 2019; 9:1222.
PMID: 31850190
PMC: 6901923.
DOI: 10.3389/fonc.2019.01222.
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset.
Agnoletto C, Corra F, Minotti L, Baldassari F, Crudele F, Cook W
Cancers (Basel). 2019; 11(4).
PMID: 30959764
PMC: 6521045.
DOI: 10.3390/cancers11040483.
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts.
Agnoletto C, Minotti L, Brulle-Soumare L, Pasquali L, Galasso M, Corra F
Biomark Res. 2018; 6:31.
PMID: 30450210
PMC: 6208170.
DOI: 10.1186/s40364-018-0145-8.
